Researchers sought to apply the clinical trial eligibility criteria for lecanemab and aducanumab treatment to patients with early AD from the MCSA study and assessed the generalizability of anti-amyloid treatment.
All articles by Peter J. Stein, PhD, DC
Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, certain features of this season’s outbreak set it apart from those of previous years.
Publish Date
-
Latest News Your top articles for Friday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses